RP-HPLC OF NEW ANTIDEPRESSANT 2-AMINO-2-OXAZOLINES - A COMPARATIVE-STUDY OF THEIR LIPOPHILICITY

被引:6
作者
DEMOTESMAINARD, F
THOMAS, J
BOSC, JJ
DEVAUX, G
JARRY, C
机构
[1] UNIV BORDEAUX 2,CHIM THERAPEUT LAB,F-33076 BORDEAUX,FRANCE
[2] UNIV BORDEAUX 2,CHIM PHYS LAB,F-33076 BORDEAUX,FRANCE
来源
JOURNAL OF LIQUID CHROMATOGRAPHY | 1993年 / 16卷 / 03期
关键词
D O I
10.1080/10826079308019563
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A comparative study of lipophilicity in a series of 5-(1-aryl-4-piperazino)methyl-2-amino-2-oxazolines with antidepressant activity has been carried out using a RP-HPLC technique. This chromatographic method allowed the determination of log k(w)' values through extrapolation to 100% water from capacity factors data. The partition coefficients (log P(o/w)) and ionization constants (pK(a)) were measured by classical methods. A good correlation between log P(o/w) and log k(w)' was found, confirming the feasibility of using the latter as a lipophilicity descriptor. In this homogeneous chemical series the nature and the position of the substituents on the aromatic ring did not induce important variations on the pK(a) values, whereas they accounted for a great part in lipophilicity data.
引用
收藏
页码:767 / 776
页数:10
相关论文
共 16 条
[1]  
Albert A., 1962, IONIZATION CONSTANTS
[2]  
BOSC JJ, 1992, IN PRESS EUR J MED C
[3]   ELECTRON-IMPACT MASS-SPECTRA OF NEW 5-SUBSTITUTED-2-AMINO-2-OXAZOLINES [J].
BOURGEOIS, G ;
JARRY, C ;
BOSC, JJ ;
DELERIS, G ;
PAYS, E .
ORGANIC MASS SPECTROMETRY, 1991, 26 (02) :109-112
[4]  
BOURIN M, 1988, ARZNEIMITTEL-FORSCH, V38-1, P666
[6]  
BROTO P, 1984, EUR J MED CHEM, V19, P71
[7]  
CALL JM, 1975, J MED CHEM, V18, P549
[8]   ESTIMATION OF MOLECULAR-PARAMETERS BY HPLC [J].
CARNEY, CF .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1985, 8 (15) :2781-2804
[9]   RP-HPLC RETENTION DATA OF NEW 2-AMINO-2-OXAZOLINES - AN APPROACH OF THEIR LIPOPHILIC PROPERTIES [J].
DEMOTESMAINARD, F ;
JARRY, C ;
THOMAS, J ;
DALLET, P .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1991, 14 (04) :795-805
[10]  
FORFAR I, 1992, IN PRESS ARCH PHARM